Incidentally Detected Thyroid Follicular Neoplasm on Somatostatin Receptor Imaging and Post-therapy Scan

Peptide receptor radionuclide therapy (PRRT) either using Lu-177 or Y-90 peptide radiopharmaceuticals has emerged as promising treatment modality in patients with inoperable metastatic neuroendocrine tumour (NET) including medullary thyroid cancer, because of overexpression of somatostatin receptor...

Descripción completa

Detalles Bibliográficos
Autores principales: Sood, Apurva, Singh, Harpreet, Sood, Ashwani, Basher, Rajender Kumar, Mittal, Bhagwant Rai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482022/
https://www.ncbi.nlm.nih.gov/pubmed/28680210
http://dx.doi.org/10.4103/ijnm.IJNM_37_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482022/
https://www.ncbi.nlm.nih.gov/pubmed/28680210
http://dx.doi.org/10.4103/ijnm.IJNM_37_17

Ejemplares similares